Crop Life Science Ltd

Crop Life Science Ltd

₹ 52.0 -3.53%
27 Nov - close price
About

Incorporated in 2006, Crop Life Sciences
Ltd manufactures and deals in pesticides, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]

Key Points

Business Overview:[1]
CLSL is an ISO 9001:2015 and ISO 14001:2004 certified manufacturer of crop protection chemicals, including Insecticides, Fungicides, Herbicides, Weedicides, Micro fertilizers, new generation organic Bio-stimulants, Bio-fertilizers, Bio-Pesticide’s plant growth regulators, and soil plant health products

  • Market Cap 89.1 Cr.
  • Current Price 52.0
  • High / Low 62.8 / 42.2
  • Stock P/E 15.9
  • Book Value 47.0
  • Dividend Yield 0.00 %
  • ROCE 10.6 %
  • ROE 7.91 %
  • Face Value 10.0

Pros

  • Stock is trading at 1.11 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Sep 2024 Mar 2025 Sep 2025
97 106 94 120
91 98 86 112
Operating Profit 6 8 8 8
OPM % 7% 8% 9% 7%
1 0 1 1
Interest 1 2 2 3
Depreciation 2 2 2 2
Profit before tax 4 4 4 4
Tax % 20% 27% 29% 29%
3 3 3 3
EPS in Rs 1.96 1.83 1.61 1.79
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
130 191 196 214
118 178 180 198
Operating Profit 12 13 16 16
OPM % 9% 7% 8% 7%
1 2 1 2
Interest 3 3 5 5
Depreciation 4 3 5 5
Profit before tax 6 8 8 8
Tax % 27% 26% 28%
4 6 6 6
EPS in Rs 3.39 3.51 3.44 3.40
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 4%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 16%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 8%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 12 17 17 17
Reserves 29 55 60 63
27 35 44 58
34 73 60 81
Total Liabilities 102 180 182 220
16 39 38 30
CWIP 0 0 0 0
Investments 0 0 1 3
86 141 143 187
Total Assets 102 180 182 220

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
2 -8 -2
-4 -3 -4
1 13 4
Net Cash Flow -2 2 -1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 92 148 129
Inventory Days 104 99 126
Days Payable 79 132 107
Cash Conversion Cycle 116 115 148
Working Capital Days 86 85 90
ROCE % 12% 11%

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
70.01% 70.01% 70.01% 70.01% 70.01%
30.00% 29.99% 29.99% 29.99% 29.99%
No. of Shareholders 2,0641,8581,6021,4651,219

Documents